
SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR-positive breast cancer
Five additional years of hormone therapy with letrozole following an initial five years of aromatase…
Five additional years of hormone therapy with letrozole following an initial five years of aromatase…